Maha revises RT-PCR rates at private labs: fixes Rs 700 for home sample

For tests conducted at laboratories in hospitals, Covid care centres and quarantine centres, Rs 500 will be charged

A health worker testing for Covid-19 collects the swab sample of a man at a railway station in Ranchi on November 27, 2021. (PTI Photo)
Representational image
Press Trust of India Mumbai
1 min read Last Updated : Dec 06 2021 | 8:52 PM IST

The Maharashtra government has revised rates for COVID-19 RT-PCR tests conducted at private laboratories, Health Minister Rajesh Tope said on Monday, adding that Rs 350 will be charged for samples taken from collection centres.

Tope said on Twitter that for tests conducted at laboratories in hospitals, COVID care centres and quarantine centres, Rs 500 will be charged. A charge of Rs 700 will be applicable if a sample is collected from home, the minister added.

No private laboratory can seek more charges than these, the minister added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Dec 06 2021 | 8:52 PM IST

Next Story